Replies to post #46263 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

These two latest drugs are related somewhat to Brilacidin and the antibiotic / antifungal areas of medicine and as such they would also have extremely short trials. We also don't know just how far along they currently are since they came in the Poly deal and so they may be just about ready for trials. Not all trials are like Kevetrin and take years per phase.

Leo is in a hard place since on one hand people condemn one trick pony stocks and then he gets a number of promising drugs and gets slapped for trying to keep too many plates in the air.

I will leave it to Dr M to determine how many projects can be efficiently handled by current staff. He seems happy so I won't find fault with current proceedings.

Have to remember that EACH of our products are in markets of $B+.

[MilesTeg]

"You're thinking gouda when it's clearly brie time, baby."

Brenum, why are you assuming that this company is incapable of handling the influx of these new drugs. K is completely out of our hands and steadily progressing through its cohorts. B seems to be being shopped at the partnership conference. P is on "hold" although that does not mean that nothing is being done with it currently.
The Polyheist was not that long ago and here we are announcing positive initial results from a couple of those aquired drugs. That seems pretty positive to me.
As far as current SP, I am in agreement that RESULTS are what will push this higher, but calling this PR "fluff" is unfair. Would you rather the company never said anything?

Part of the problem is our demand for instant gratification, via higher SP, but that is just not how the markets work.

MT

[BonelessCat]

You must have missed the PR and filings showing CTIX is no longer a 2 person operation and now has a specialist in each area of development.

All of which considerably tax the time and resources from Leo, one person.

[vip1999]

When new revenue comes in, they will have plenty of pipeline to work on. It is their way of keeping us updated as new development happens. it is all good.